Skip to main content

Candel Therapeutics, Inc 10-K for FY2025

Candel Therapeutics, Inc. (CADL)

10-K 2026-03-12 For: 2025-12-31
View Original
Added on April 10, 2026

About this 10-K

Candel Therapeutics, Inc filed this 10-K on March 12, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$38.18M
compared with a net loss of $55.18M a year earlier
Diluted EPS
-$0.72
compared with -$1.74 a year earlier